Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043502 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Przemek A Gorski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Heart Failure, p300-CBP Transcription Factors, Protein Processing, Post-Translational, Sarcoplasmic Reticulum Calcium-Transporting ATPases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Impaired calcium uptake resulting from reduced expression and activity of the cardiac sarco-endoplasmic reticulum Ca2+ ATPase (SERCA2a) is a hallmark of heart failure (HF). Recently, new mechanisms of SERCA2a regulation, including post-translational modifications (PTMs), have emerged. Our latest analysis of SERCA2a PTMs has identified lysine acetylation as another PTM which might play a significant role in regulating SERCA2a activity. SERCA2a is acetylated, and that acetylation is more prominent in failing human hearts. In this study, we confirmed that p300 interacts with and acetylates SERCA2a in cardiac tissues. Several lysine residues in SERCA2a modulated by p300 were identified using in vitro acetylation assay. Analysis of in vitro acetylated SERCA2a revealed several lysine residues in SERCA2a susceptible to acetylation by p300. Among them, SERCA2a Lys514 (K514) was confirmed to be essential for SERCA2a activity and stability using an acetylated mimicking mutant. Finally, the reintroduction of an acetyl-mimicking mutant of SERCA2a (K514Q) into SERCA2 knockout cardiomyocytes resulted in deteriorated cardiomyocyte function. Taken together, our data demonstrated that p300-mediated acetylation of SERCA2a is a critical PTM that decreases the pump’s function and contributes to cardiac impairment in HF. SERCA2a acetylation can be targeted for therapeutic aims for the treatment of HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Research Institute for Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- New Drug Development Center, Osong Medical Innovation Fundation, Osong, Seoul 02841, Republic of Korea.
- Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
- Phospholamban Foundation, 1775 ZH Amsterdam, The Netherlands.
- Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
ORCID-Profile: Peter Vangheluwe, Changwon Kho
Förderung
- National Research Foundation of Korea
Zitieren
APA
Gorski, P. A., Lee, A., Lee, P., Oh, J. G., Vangheluwe, P., Ishikawa, K., Hajjar, R., & Kho, C. (2023). Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043502
Vancouver
Gorski PA, Lee A, Lee P, Oh JG, Vangheluwe P, Ishikawa K, et al. Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043502
BibTeX
@article{Gorski2023,
author = {Gorski, Przemek A and Lee, Ahyoung and Lee, Philyoung and Oh, Jae Gyun and Vangheluwe, Peter and Ishikawa, Kiyotake and Hajjar, Roger and Kho, Changwon},
title = {Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043502}
}
EUVIMED